Nuveen LLC Invests $2.87 Million in Schrodinger, Inc. $SDGR

Key Points

• Nuveen LLC has made a new investment in Schrodinger, Inc. ($SDGR), acquiring 145,488 shares valued at approximately $2.87 million, which represents 0.20% of the company.
• Schrodinger reported a 15.7% increase in quarterly revenue year-over-year, totaling $54.76 million, and beat earnings per share estimates with an EPS of ($0.59).
• Recent analyst ratings for Schrodinger show mixed sentiment, with Citigroup downgrading the stock while others like Barclays initiated coverage with an "overweight" rating and a price target of $25.00.

Nuveen LLC acquired a new stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 145,488 shares of the company's stock, valued at approximately $2,872,000. Nuveen LLC owned 0.20% of Schrodinger at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in SDGR. Raymond James Financial Inc. acquired a new position in shares of Schrodinger in the fourth quarter valued at approximately $325,000. MetLife Investment Management LLC boosted its holdings in Schrodinger by 5.6% in the fourth quarter. MetLife Investment Management LLC now owns 34,554 shares of the company's stock valued at $667,000 after acquiring an additional 1,825 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Schrodinger by 8.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 42,009 shares of the company's stock valued at $811,000 after acquiring an additional 3,376 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in Schrodinger in the fourth quarter valued at approximately $965,000. Finally, Northern Trust Corp boosted its holdings in Schrodinger by 11.3% in the fourth quarter. Northern Trust Corp now owns 602,618 shares of the company's stock valued at $11,625,000 after acquiring an additional 60,987 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Schrodinger Stock Up 0.9%

SDGR traded up $0.18 during trading on Wednesday, hitting $19.29. The company's stock had a trading volume of 792,258 shares, compared to its average volume of 1,340,528. Schrodinger, Inc. has a twelve month low of $16.60 and a twelve month high of $28.47. The stock's fifty day moving average price is $20.46 and its 200-day moving average price is $21.86. The firm has a market capitalization of $1.42 billion, a P/E ratio of -7.78 and a beta of 1.79.

Schrodinger (NASDAQ:SDGR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.24. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The firm had revenue of $54.76 million for the quarter, compared to analyst estimates of $52.03 million. During the same period in the previous year, the firm earned ($0.66) earnings per share. The company's revenue was up 15.7% compared to the same quarter last year. Equities research analysts expect that Schrodinger, Inc. will post -2.37 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Citigroup cut Schrodinger from a "buy" rating to a "neutral" rating and reduced their target price for the company from $35.00 to $20.00 in a report on Friday, August 15th. Barclays assumed coverage on Schrodinger in a report on Thursday, August 14th. They issued an "overweight" rating and a $25.00 target price on the stock. KeyCorp reduced their target price on Schrodinger from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. Wall Street Zen cut Schrodinger from a "hold" rating to a "sell" rating in a report on Saturday. Finally, Morgan Stanley reduced their target price on Schrodinger from $28.00 to $19.00 and set an "equal weight" rating on the stock in a report on Monday, August 18th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $27.83.

Schrodinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.